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Temperature-sensitivityA lysine at the 627 position (627K) of PB2 protein of inﬂuenza virus has been recognized as a determinant for
host adaptation and a virulent element for some inﬂuenza viruses. While seasonal inﬂuenza viruses
exclusively contained 627K, the pandemic (H1N1) 2009 possessed a glutamic acid (627E), even after
circulation in humans for more than 6 months. To explore the potential role of E627K substitution in PB2 in
the pandemic (H1N1) 2009 virus, we compared pathogenicity and growth properties between a
recombinant virus containing 627K PB2 gene and the parental A/California/4/2009 strain containing
627E. Our results showed that substitution of 627K in PB2 gene does not confer higher virulence and growth
rate for the pandemic (H1N1) 2009 virus in mice and cell culture respectively, suggesting 627K is not
required for human adaptation of the pandemic (H1N1) 2009 virus.erging Infectious Diseases and
e, TheUniversity ofHongKong,
guan@hkucc.hku.hk (Y. Guan).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
After introduction into humans, a swine-origin inﬂuenza A H1N1
virus (S-OIV) has rapidly caused global transmission in a couple of
months and led to the declaration of the 2009 pandemic by World
Health Organization on June 11, 2009. Although the overall clinical
symptoms of the disease are mild and similar to those caused by
seasonal inﬂuenza, there have been severe cases and it has claimed
over 5700 human lives worldwide by the end of October, 2009
(http://www.who.int/csr/don/2009_10_30/en/index.html). Genet-
ic analysis showed the pandemic (H1N1) 2009 virus has undergone
very limited genetic mutations up to now (http://www.who.int/csr/
don/2009_10_16/en/index.html). The virulence markers which were
frequently observed in avian H5N1 virus infection of mammals were
absent (Neumann et al., 2009). However, there is still a concern that
the pandemic (H1N1) 2009 virus may evolve into a more virulent
form as that observed in the “Spanish ﬂu” during the fall of 1918.
Pathogenicity of inﬂuenza virus involves polygenic traits. Residue
627 of the polymerase basic protein 2 (PB2) was recognized as one of
the most important determinants (Subbarao et al., 1993; Hatta et al.,2001). The E627K substitutionwas observed to enhance virulence and
viral replication in mice and other mammals (Mase et al., 2006;
Manzoor et al., 2009; Steel et al., 2009; Le et al., 2009). It was also
reported to contribute to the improved replication of H5N1 inﬂuenza
virus at the lower temperature of 33 °C, thus conferring to the virus
advantages for efﬁcient growth in the upper respiratory tracts of
mammals and transmission (Massin et al., 2001; Hatta et al., 2007;
Steel et al., 2009; Van Hoeven et al., 2009). Notably, all previous
human inﬂuenza viruses established through the three pandemics in
the 20th century contained 627K in PB2, while most of avian inﬂuenza
viruses carried glutamic acid (E) instead. Genetic analysis showed that
swine inﬂuenza viruses had either K or E at this position and current
human pandemic (H1N1) 2009 viruses possessed a 627E (Inﬂuenza
Virus Resource, NCBI, www.ncbi.nlm.nih.gov/genomes/FLU/).
Whether the substitution of E627K in PB2 gene of the pandemic
(H1N1) 2009 virus may occur after prevailing in humans for a period
of time, and whether such change may alter the virulence of the
current pandemic H1N1 virus is still unknown.
To investigate the potential pathogenic effect of PB2 E627K sub-
stitution in the pandemic (H1N1) 2009 virus, we reconstructed a
recombinant virus with a single residue substitution at PB2 627
position from the A/California/04/2009 strain and tested its patho-
genicity in mice and its growth properties in MDCK cells under
different temperatures. Our ﬁndings suggested that a 627K substitu-
tion in PB2 gene does not confer higher virulence or growth properties
for the pandemic (H1N1) 2009 virus.
Fig. 2. Effects of PB2 E627K substitution on virus replication in lung tissues of infected
mice. Twenty-twomice per groupwere intranasally inoculated with PBS (mock), 103 or
105 PFU (each in 25 μl of PBS) of reverse genetics-derived viruses respectively. On days
1, 2, 3, 4, and 7 post-infection (d.p.i.), three mice from each group were euthanized.
Virus titer and viral RNA level in lung homogenate of each mouse were determined by
plaque assay (a) and quantitative RT-PCR (b) as described in the Materials and
methods. The values are means (±standard deviation) of three mice.
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Effects of PB2 E627K substitution on the viral replication and
pathogenicity of A/California/04/2009 (H1N1) virus in mice
To assess the potential effect of a PB2 E627K substitution on the
pandemic (H1N1) 2009 virus, we constructed a recombinant virus by
introducing a lysine into the 627 position of PB2 gene in the background
of A/California/04/2009 (CA04). The pathogenicity and viral growth
properties in the lung tissueswere compared between the reconstituted
wild-type CA04 627E and its 627K counterpart in infectedmice. Groups
of 22 mice were inoculated with 103 or 105 PFU of viruses respectively.
The clinical signs and body weight change from the infected mice were
monitored daily for 14 days. Our results showed that inoculation of
CA04-RG-627E or CA04-RG-627K viruseswith either 103 or 105 PFUwas
not lethal to mice. Mice infected with a 105 PFU dose of either virus
experiencedbodyweight loss startingon2 d.p.i., and reached the lowest
level on 6 d.p.i. However, there was no signiﬁcant difference between
the CA04-RG-627E and the CA04-RG-627K groups (PN0.05) (Fig. 1).
Overt clinical signs were observed on 3–4 d.p.i., when most infected
mice in these groups suffered from inactivity, anorexia and rufﬂed fur.
Animals infected with a lower dose of either viruses (103 PFU) showed
milder symptoms and lessweight loss (Pb0.001), compared with those
from the higher dose inoculation groups (Fig. 1).Mice infectedwith 103
PFU of CA04-RG-627K virus had slightly less weight loss than those
infected with the same dose of CA04-RG-627E virus throughout the
course of the experiment (Pb0.001) (Fig. 1).
CA04 virus was reported to cause prominent bronchitis, alveolitis
and efﬁcient viral replication in the lung tissues of infected mice (Itoh
et al., 2009). In this study, we examined virus replication in trachea,
lungs, intestines and brain tissues of the infected mice. No virus
replication was observed beyond the pulmonary system of mice
infected with either CA04-RG-627E or CA04-RG-627K virus by
histochemical staining of viral nucleoprotein (data not shown).
Notably, viral replication was observed in mice lungs from the ﬁrst
day post-infection (Fig. 2), implicating the tendency of replication in
the lower respiratory tract by the pandemic (H1N1) 2009 virus.
Consistent with the observation of body weight changes, virus growth
in lung tissue was observed during the ﬁrst 4 days post-infection
(Fig. 2), and a lower dose of virus inoculation resulted in less severe
lung lesions, with viral antigen (nucleoprotein, NP)mostly detected in
the terminal bronchiolar epithelia and desquamated cells in the
bronchiolar lumen (Fig. 3). Examination of virus replication activity
with quantitative RT-PCR found that virus replication reached the
highest level on the ﬁrst 2 days post-infection, decreased gradually
thereafter; and virus was cleared after 7 days post-infection (Fig. 2b).
Although 627K of PB2 gene was reported to associate with increasedFig. 1. Body weight changes in infected mice. Twenty-two mice per group were intranasally
derived viruses. Body weights were monitored daily for 14 days or prior to the sacriﬁce of ea
PFU of CA04-RG-K virus (containing 627K) in mice respectively, while groups of 627E3 and
respectively. The values are means (±standard deviation) from each group.virus replication, our results found no signiﬁcant difference in
virulence and virus replication in lung tissues of infected mice with
the PB2 627K and 627E viruses derived from the pandemic (H1N1)
2009 virus (PN0.05) (Figs. 2 and 3). It is important to note that while
mice infectedwith 105 PFU of viruses exhibitedmore bodyweight loss
(Fig. 1), examination of virus titer in lung tissues found that there was
a signiﬁcant reduction in virus titer from a 105 PFU dose of both 627E
and 627K groups on day 7 post-infection (Fig. 2a). It remains to be
investigated if inoculation with a higher dose of virus may induce a
stronger host immune response, leading to the rapid clearness of virus
in the lung.
Effects of PB2 E627K substitution on the growth property of CA04 on
MDCK cells at different temperatures
The E627K substitution in PB2 gene of avian H5N1 inﬂuenza virus
was reported to be responsible for the increased growth efﬁciency ininoculated with PBS (mock), 103 or 105 PFU (each in 25 μl of PBS) of reverse genetics-
ch experimental mouse. Groups of 627K3 and 627K5 represent infection with 103 or 105
627E5 represent infection with 103 or 105 PFU of CA04-RG-E virus (containing 627 E)
Fig. 3. Histochemical staining of viral nucleoprotein in lung tissues of infected mice (represented by 4 days post-infection). Viral antigen (nucleoprotein, NP) was detected with a
mouse anti-NP monoclonal antibody, mainly observed in the terminal bronchiolar epithelia and desquamated cells in the bronchiolar lumen. Original magniﬁcation: 200×.
3Rapid Communicationmammals, especially at lower temperatures of 32–33 °C (Massin et al.
2001; Hatta et al., 2007). Our animal experiment showed CA04-RG-
627K did not change growth properties of the pandemic (H1N1) 2009
virus in mouse lung tissues, with the body temperature at approx. 37–
39 °C. We then further characterized the growth kinetics of CA04-RG-Fig. 4. Growth properties of reconstituted A/California/04/2009 (H1N1) virus and the PB2
genetics-derived viruses with a wild-type PB2 627E (CA04-RG-E) or a 627K variant (CA04-R
Aliquots of the supernatants were collected and titrated by quantitative RT-PCR. The values627E and CA04-RG-627K viruses at different temperatures in MDCK
cells. Both viruses were shown to be sensitive to temperature change
and had severe growth delay at 33 °C (Pb0.01) during the ﬁrst 48 h.p.i
(Fig. 4). No signiﬁcant difference was observed between these two
viruses in replication kinetics at all temperatures tested (33–39°C)627K variant in MDCK cells at different temperatures. Cells were infected with reverse
G-K) at a MOI of 0.001. Infected cells were incubated at 33, 35, 37 or 39 °C as indicated.
are means (±SD) of three independent determinations.
4 Rapid Communication(PN0.05), suggesting PB2 627K did not confer any advantage over
627E for the growth of pandemic (H1N1) 2009 virus in MDCK cells.
Estimation of virus titer in MDCK culture with plaque assay found a
similar result (Supplementary Fig. S1).
Discussion
Increasing evidence strongly suggested that the amino acid at 627
position of the polymerase basic protein 2 (PB2) is associated with
host range adaptation (Subbarao et al., 1993; Gabriel et al., 2007;
Labadie et al., 2007). Of note, most avian and all equine inﬂuenza
viruses have a glutamic acid (E), so does the pandemic (H1N1) 2009
virus. By contrast, human inﬂuenza viruses established in the last
century exclusively contained a lysine (K), while viruses from pigs
possessed either E or K in 627 position of PB2 gene (according to
sequences released in Inﬂuenza Virus Resource, NCBI, www.ncbi.nlm.
nih.gov/genomes/FLU/ up to Nov 19, 2009).
Studies on viral pathogenicity revealed that a single amino acid
substitution of E627K in PB2 would remarkably enhance the virulence
of avian H5N1 and equine H7N7 inﬂuenza viruses in mammalian
species (Hatta et al., 2001; Shinya et al., 2007; Munster et al., 2007).
Most strikingly, a single passage in mice was reported to be sufﬁcient
for the avian H5N1 virus to acquire the E627K substitution, and all
recovered viruses from the brains of dead mice turned out to have a
627K (Mase et al., 2006). In addition to H5 and H7 subtypes, PB2 627K
was also found to confer increased transmission and plaque-forming
abilities for human H3N2 and pandemic 1918 strain (Van Hoeven
et al., 2009; Steel et al., 2009). As such, a lysine at PB2 627 position has
been considered as one of the most important determinants of
pathogenicity and host range for inﬂuenza viruses. Whether current
pandemic H1N1 virus may evolve to obtain E627K substitution
remains to be seen. However, it would be important to examine if the
627K variant may result in altered virulence in animal models, which
would have a signiﬁcant implication on this undergoing pandemic.
In this study, we demonstrated that the single amino acid sub-
stitution of PB2 E627K, in the context of the current inﬂuenza
pandemic stain, rendered neither increased pathogenicity inmice, nor
improved viral replication in MDCK cells under 33–39 °C. As the
normal temperatures of human distal and proximal airways are
approximately within this range, a reasonable predictive implication
can be deduced that a lysine at PB2 627 position might not confer
improved viral replication and virulence in humans.
The difference on effects of the PB2 627K residue in pandemic
(H1N1) 2009 from this study and previous reports mainly in H5N1
and H7N7 subtypes may be due to the different interactions between
PB2 and other viral genes in the different genetic context of these
viruses. It was reported that increased virulence in mice caused by the
E627K mutation in H5N1 avian inﬂuenza virus could be compensated
bymultiple mutations at other sites of PB2 gene (L89V, G309D, T339K,
R477G, I495V and A676T), suggesting that E627K substitution may
not be an indispensable determinant for virulence (Li et al., 2009).
Genetic analysis revealed that the pandemic (H1N1) 2009 contained
all six “compensating” residues in PB2 gene. In another study,
substitutions at 590 and 591 positions in PB2 gene was reported to
act as adaptive strategies for the pandemic (H1N1) 2009 virus
polymerase to replicate in humans (Mehle and Doudna, 2009). These
evidences may partially explain why the pandemic (H1N1) 2009 virus
can replicate and transmit efﬁciently in humans without the function
of PB2 627K.
With the pandemic (H1N1) 2009 virus continues to circulate in
humans, it is likely that more adaptive mutations will emerge along
the course of transmission in humans. Acquisition of possible path-
ogenic determinants through mutation or gene reassortment with
other inﬂuenza viruses may generate more virulent variants. Our
study, however, suggested that the 627K mutation in PB2 alone, if it
occurs, may not raise the risk signiﬁcantly.Materials and methods
Viruses and cells
The reference human H1N1 virus, A/California/04/2009 (CA04),
was kindly provided by the World Health Organization Collaborating
Centers for Reference and Research on Inﬂuenza (Atlanta, GA, USA).
Madin-Darby canine kidney (MDCK) and human embryonic kidney
(HEK) 293T cells were obtained from the American Type Culture
Collection (ATCC) and propagated in Eagle's minimal essential
medium (MEM) and Dulbecco's modiﬁed Eagle's medium (DMEM)
with 10% fetal bovine serum (FBS), respectively. Viral stocks were
prepared in MDCK cells. All experiments with live viruses and
transfectants were conducted in biosafety level 3 (BSL3) containment
laboratories.
Generation of recombinant viruses by reverse genetics
The CA04-derived recombinant viruses were generated as previ-
ously reported (Hoffmann et al., 2001). In brief, viral RNA was
extracted fromCA04 stocks usingQIAampviral RNAminikit (QIAGEN).
The cDNAs was synthesized with Uni12 primer using Transcriptor
High Fidelity cDNA synthesis Kit (Roche). All eight viral genes of CA04
were ampliﬁed using PfuUltra® II Fusion HS DNA Polymerase
(Stratagene) and cloned into pHW2000 plasmid. QuikChange® II
Site-DirectedMutagenesis Kit (Stratagene) was used for generation of
E627K mutations in PB2 gene. All plasmids were sequenced to ensure
the absence of unwanted mutations.
The rescue of infectious virus from cloned cDNA was conducted as
previously described (Hoffmann et al., 2000). Brieﬂy, 293T cells were
co-cultured with MDCK cells in opti-modiﬁed Eagle's medium (Opti-
MEM) (Gibco/Life technologies) supplemented with 1.5% (v/v) of
Antibiotic Antimycotic Solution (100×) (Sigma). After overnight in-
cubation, sub-conﬂuent (70%) monolayers were used for co-transfec-
tion with eight plasmids (1 μg each plasmid) using TransIT®-LT1
Transfection Reagent (Mirus). 48–72 h after transfection, culture
supernatant was inoculated to MDCK cells and then passaged for
preparation of viral stocks. Identities of the recombinant viruses were
conﬁrmed by sequencing before the animal test. The reverse genetics-
derived virus with all wild-type gene segments of CA04 was
designated as CA04-RG-E while that with a single E627K substitution
in PB2 gene as CA04-RG-K.
Virus growth kinetics in MDCK cell culture
MDCK cells were infected with each virus in triplicate at a
multiplicity of infection (MOI) of 0.001 and incubated at 33, 35, 37 or
39 °C. Aliquots of the supernatants were collected at 6, 12, 24, 36, 48,
60, 72 and 78 h post-inoculation (h.p.i.) and titrated by real-time RT-
PCR and plaque assay on MDCK cells.
Pathogenicity test in mice
Eight- to nine-week-old female BALB/c mice were used in this
study. Baseline body weights were established prior to infection.
Twenty-two mice per group were intranasally inoculated with 103 or
105 PFU (plaque-forming unit) of viruses in 25 μl of PBS under light
anaesthesia by inhalation of 4% isoﬂurane. For themock group, 25 μl of
PBS was used. Body weight, clinical signs of infection, and survival
were monitored daily for 14 days and mice with body weight loss
greater than 25% of pre-infection values were euthanized humanely.
Three mice from each group were sacriﬁced respectively on days 1, 2,
3, 4, 7 post-infection (d.p.i.). The remainders (7 mice per group) were
kept for observation and euthanatized at the end of the experiment
(14 d.p.i.).
5Rapid CommunicationViral titration from the mouse organs
Tissues for viral titrations were removed and kept at−80 °C until
homogenized in a 9 fold volume of cold PBS and clariﬁed by cen-
trifugation. Virus titers of homogenates were determined by plaque
assays in MDCK cells and by real-time PCR.
Pathological examination
Freshly excised tissues of the trachea, lungs, intestines and brains
from the mice were preserved in 10% phosphate-buffered formalin.
After 24 h' ﬁxation, tissues were dehydrated, embedded in parafﬁn,
and cut into 5-μm-thick sections. For sections from each tissue
sample, a standard histochemistry staining procedure with hema-
toxylin and eosin (Sigma) (H&E) as well as immunohistochemistry
(IHC) assay with amouse anti-NPmonoclonal antibody (provided by
the National Institute of Diagnostics and Vaccine Development for
Infectious Diseases, Xiamen University) was performed in parallel.
Goat anti-mouse IgG–biotin conjugate secondary antibody was
purchased from Calbiochem. Speciﬁc viral antigen was visualized
by 3,3′-diaminobenzidaine tetrahydrochloride staining as brown.
Nine discrete, non-overlapping ﬁelds of view with a magniﬁcation of
400× were observed for each section and the number of positive
viral antigen was calculated.
Real-time RT-PCR
Viral RNAwas extracted from CA04 stocks using QIAamp viral RNA
minikit (QIAGEN) and cDNAswere synthesizedwith Uni12 or random
primers using Transcriptor High Fidelity cDNA synthesis Kit (Roche).
Copy numbers of the inﬂuenza M segment were determined on a
LightCycler® 480 Real-Time PCR System (Roche) with LightCycler®
FastStart DNAMasterPLUS SYBR Green I Kit (Roche) and normalized by
the expression of β-Actin gene. Primers used for the analysis of M
gene were M-146F (GACCRATCCTGTCACCTCTGAC) and M-251R
(AGGGCATTYTGGACAAAKCGTCTA), while those for β-Actin gene
were Act-1132F (TGGATCAGCAAGCAGGAGTATG) and Act-1188R
(GCATTTGCGGTGGACGAT).
Statistical analysis
Statistical analysis was performed by Mean Analysis with PASW
Statistics 18 (SPSS Inc., Chicago IL). The probability of a signiﬁcant
difference was computed using ANOVA (analysis of variance). Results
were considered signiﬁcant at Pb0.05.
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